Company: ABBV
Filing Date: 2025-05-09
Form Type: 10-Q
Source: 0001551152-25-000029
Chunk: 19

Company: AbbVie Inc.
Filing Date: 2025-05-09
Form: 10-Q
Item: Part I, Item 1
Chunk 19
---
1,593 — Proceeds from issuance of other short-term borrowings— 5,008 Repayments of other short-term borrowings— (5,005)Proceeds from issuance of long-term debt3,994 14,963 Repayments of long-term debt and finance lease obligations(3,026)(103)Debt issuance costs(20)(99)Dividends paid(2,925)(2,772)Purchases of treasury stock(961)(1,324)Proceeds from the exercise of stock options56 127 Other, net31 24 Cash flows from financing activities(1,258)10,819 Effect of exchange rate changes on cash and equivalents9 (18)Net change in cash and equivalents(349)5,253 Cash and equivalents, beginning of period5,524 12,814 Cash and equivalents, end of period$5,175 $18,067 

The accompanying notes are an integral part of these condensed consolidated financial statements.

2025 Form 10-Q | 5

AbbVie Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements (unaudited)

Note 1 Basis of Presentation Basis of Historical Presentation 

The unaudited interim condensed consolidated financial statements of AbbVie Inc. (AbbVie or the company) have been prepared pursuant to the rules and regulations of the United States Securities and Exchange Commission. Accordingly, certain information and footnote disclosures normally included in annual financial statements prepared in accordance with generally accepted accounting principles in the United States (U.S. GAAP) have been omitted. These unaudited interim condensed consolidated financial statements should be read in conjunction with the company’s audited consolidated financial statements and notes included in the company’s Annual Report on Form 10-K for the year ended December 31, 2024.It is management’s opinion that these financial statements include all normal and recurring adjustments necessary for a fair presentation of the company’s financial position and operating results. Net revenues and net earnings for any interim period are not necessarily indicative of future or annual results. Certain other reclassifications were made to conform the prior period interim condensed consolidated financial statements to the current period presentation.Recent Accounting PronouncementsRecent Accounting Pronouncements Not Yet AdoptedASU No. 2024-03In November 2024, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2024-03, Income Statement-Reporting Comprehensive